Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1955 1
1957 1
1960 2
1962 1
1963 4
1964 3
1965 3
1966 2
1967 4
1968 4
1969 6
1970 10
1971 8
1972 4
1973 5
1974 5
1975 8
1976 5
1977 5
1978 12
1979 13
1980 20
1981 12
1982 19
1983 16
1984 9
1985 15
1986 14
1987 15
1988 17
1989 21
1990 18
1991 21
1992 8
1993 18
1994 23
1995 21
1996 17
1997 11
1998 23
1999 24
2000 18
2001 29
2002 28
2003 26
2004 28
2005 31
2006 42
2007 37
2008 42
2009 54
2010 69
2011 35
2012 45
2013 48
2014 38
2015 66
2016 69
2017 75
2018 71
2019 75
2020 82
2021 89
2022 101
2023 82
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

1,576 results

Results by year

Filters applied: . Clear all
Page 1
In Reply.
Tanizaki J, Chiba Y, Haratani K, Hayashi H, Nakagawa K. Tanizaki J, et al. Among authors: chiba y. J Thorac Oncol. 2018 May;13(5):e86-e87. doi: 10.1016/j.jtho.2018.02.003. J Thorac Oncol. 2018. PMID: 29703548 Free article. No abstract available.
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE).
Haratani K, Nakamura A, Mamesaya N, Mitsuoka S, Yoneshima Y, Saito R, Tanizaki J, Fujisaka Y, Hata A, Tsuruno K, Sakamoto T, Teraoka S, Oki M, Watanabe H, Sato Y, Nakano Y, Otani T, Sakai K, Tomida S, Chiba Y, Ito A, Nishio K, Yamamoto N, Nakagawa K, Hayashi H. Haratani K, et al. Among authors: chiba y. J Thorac Oncol. 2023 Oct;18(10):1334-1350. doi: 10.1016/j.jtho.2023.06.012. Epub 2023 Jun 25. J Thorac Oncol. 2023. PMID: 37364849
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer.
Yonesaka K, Tanizaki J, Maenishi O, Haratani K, Kawakami H, Tanaka K, Hayashi H, Sakai K, Chiba Y, Tsuya A, Goto H, Otsuka E, Okida H, Kobayashi M, Yoshimoto R, Funabashi M, Hashimoto Y, Hirotani K, Kagari T, Nishio K, Nakagawa K. Yonesaka K, et al. Among authors: chiba y. Clin Cancer Res. 2022 Jan 15;28(2):390-403. doi: 10.1158/1078-0432.CCR-21-3359. Epub 2021 Dec 17. Clin Cancer Res. 2022. PMID: 34921025
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Isomoto K, Haratani K, Hayashi H, Shimizu S, Tomida S, Niwa T, Yokoyama T, Fukuda Y, Chiba Y, Kato R, Tanizaki J, Tanaka K, Takeda M, Ogura T, Ishida T, Ito A, Nakagawa K. Isomoto K, et al. Among authors: chiba y. Clin Cancer Res. 2020 Apr 15;26(8):2037-2046. doi: 10.1158/1078-0432.CCR-19-2027. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937613
Structural basis for activation of DNMT1.
Kikuchi A, Onoda H, Yamaguchi K, Kori S, Matsuzawa S, Chiba Y, Tanimoto S, Yoshimi S, Sato H, Yamagata A, Shirouzu M, Adachi N, Sharif J, Koseki H, Nishiyama A, Nakanishi M, Defossez PA, Arita K. Kikuchi A, et al. Among authors: chiba y. Nat Commun. 2022 Nov 21;13(1):7130. doi: 10.1038/s41467-022-34779-4. Nat Commun. 2022. PMID: 36414620 Free PMC article.
Plasma membrane phosphatidylinositol (4,5)-bisphosphate is critical for determination of epithelial characteristics.
Kanemaru K, Shimozawa M, Kitamata M, Furuishi R, Kayano H, Sukawa Y, Chiba Y, Fukuyama T, Hasegawa J, Nakanishi H, Kishimoto T, Tsujita K, Tanaka K, Itoh T, Sasaki J, Sasaki T, Fukami K, Nakamura Y. Kanemaru K, et al. Among authors: chiba y. Nat Commun. 2022 May 9;13(1):2347. doi: 10.1038/s41467-022-30061-9. Nat Commun. 2022. PMID: 35534464 Free PMC article.
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study.
Kurosaki T, Chamoto K, Suzuki S, Kanemura H, Mitani S, Tanaka K, Kawakami H, Kishimoto Y, Haku Y, Ito K, Sato T, Suminaka C, Yamaki M, Chiba Y, Yaguchi T, Omori K, Kobayashi T, Nakagawa K, Honjo T, Hayashi H. Kurosaki T, et al. Among authors: chiba y. Front Immunol. 2023 Dec 11;14:1325462. doi: 10.3389/fimmu.2023.1325462. eCollection 2023. Front Immunol. 2023. PMID: 38149256 Free PMC article.
1,576 results